CSF2 and cervical squamous intraepithelial neoplasia: In the management of CIN, myeloid growth factors (MGFs), including G-CSF and granulocyte macrophage-colony stimulating factor (GM-CSF), are approved for clinical practice to reduce the risk of FN and its complications.